Back
180 Life Sciences Vs. GT Biopharma Industry Stock Comparison
Sell
17
ATNF
180 Life Sciences
Last Price:
1.70
Seasonality Move:
-36.3%
Sell
44
GTBP
GT Biopharma
Last Price:
2.11
Seasonality Move:
0.04%
Sell
17
180 Life Sciences (ATNF)
is a Sell
Is 180 Life Sciences a Buy, Sell or Hold?
- The current 180 Life Sciences [ATNF] share price is $1.68. The Score for ATNF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- ATNF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $2.12. The Score for GTBP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- GTBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATNF Stock Price Chart
What is 180 Life Sciences's stock price today?
-
The 180 Life Sciences share price today is $1.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNF is experiencing selling pressure, which indicates risk of future bearish movement.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $2.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight buying pressure.
ATNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 42.11 | Sell |
Chaikin Money Flow: | -32384 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.76 - 2.06) | Sell |
Bollinger Bands (100): | (1.6 - 2.14) | Sell |
GTBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 48 | Sell |
Chaikin Money Flow: | 722 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.04 - 2.2) | Sell |
Bollinger Bands (100): | (1.99 - 3.57) | Sell |
ATNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.87 | Sell |
20-day SMA: | 1.9 | Sell |
50-day SMA: | 1.95 | Sell |
200-day SMA: | 2.56 | Sell |
8-day EMA: | 1.82 | Sell |
20-day EMA: | 1.88 | Sell |
50-day EMA: | 1.91 | Sell |
200-day EMA: | 10.16 | Sell |
GTBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.07 | Buy |
20-day SMA: | 2.1 | Buy |
50-day SMA: | 2.28 | Sell |
200-day SMA: | 3.98 | Sell |
8-day EMA: | 2.08 | Buy |
20-day EMA: | 2.12 | Buy |
50-day EMA: | 2.32 | Sell |
200-day EMA: | 4.87 | Sell |
180 Life Sciences Earnings Growth & ATNF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.00 per share, and a decrease next year of $0.00 per share.
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $3.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
180 Life Sciences Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
GT Biopharma Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |